活性分子抑制剂-Amadis Chemical

图片	名称及描述
	ZL0454 ZL0454 A10198992229042-77-5 97%	Detail
	(2S,4R)-1-((S)-2-(7-(4-(6-((6-乙酰基-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-2-基)氨基)吡啶-3-基)哌嗪-1-基)-7-氧代庚酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 XY028-133 A10199232229974-73-4 97%	Detail
	2-(二乙基氨基)-5-羟基-6-碘-7-(1H-吡咯-1-基)苯并[d]噻唑-4-羧酸 MB710 A10199372230044-57-0 98%	Detail
	XPC-6444 XPC-6444 A10199412230144-21-3 97%	Detail
	Tinengotinib Tinengotinib A10199542230490-29-4 97%	Detail
	ZL0420 ZL0420 A10199572230496-80-5 97%	Detail
	ZL0590 ZL0590 A10199602230496-99-6 97%	Detail
	Vibostolimab Vibostolimab A10200082231305-30-7 97%	Detail
	Tubulin inhibitor 1 Tubulin inhibitor 1 A10200962237054-53-2 97%	Detail
	(R)-2-乙酰氨基-3-((2-氨基-9-(4-氯苄基)-6-氧代-6,9-二氢-3H-嘌呤-8-基)硫代)丙酸 E3 ligase Ligand 18 A10201622241669-88-3 98%	Detail
	2-((Z)-2-(((Z)-4-异丙基亚苄基)肼亚基)-4-氧代噻唑烷-5-基)乙酸 VPC-18005 A10201802242480-48-2 97%	Detail
	(S)-N-(1-((4-(N-(叔丁基)氨基磺酰基)苯基)氨基)-1-氧代-3-苯基丙-2-基)-4-氟苯甲酰胺 CMPD-39 A10201832242582-40-5 98%	Detail
	特拉佐利单抗 Tesnatilimab A10201972242758-08-1 97%	Detail
	ZXH-3-26 ZXH-3-26 A10202042243076-67-5 97%	Detail
	Vixarelimab Vixarelimab A10202112243320-83-2 97%	Detail
	LRH-1 modulator-1 LRH-1 modulator-1 A10202702244781-29-9 98%	Detail
	WS-383 hydrochloride WS-383 hydrochloride A10203972247544-02-9 98%	Detail
	(3R)-N-[2-(5-氟-3-吡啶基)-8-(1-甲基乙基)吡唑并[1,5-a]-1,3,5-三嗪-4-基 ]-2,3,4,9-四氢-1H-咔唑-3-胺 AHR antagonist 5 free base A10204112247950-42-9 97%	Detail
	N-(2-(2-(2-(4-(4-((5-氯-4-((2-(异丙基磺酰)苯基)氨基)嘧啶-2-基)氨基)苯基)哌嗪-1-基)乙氧基)乙氧基)乙基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氨基)乙酰胺 TL12-186 A10204832250025-88-6 97%	Detail
	N,N'-(癸烷-1,10-二基)双(2-((S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮卓-6-基)乙酰胺),MS645 MS645 A10204992250091-96-2 98%	Detail